Centre d'Information et de documentation du CRA Rhône-Alpes
CRA
Informations pratiques
-
Adresse
Centre d'information et de documentation
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexHoraires
Lundi au Vendredi
9h00-12h00 13h30-16h00Contact
Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Détail de l'auteur
Auteur Maclain CAPRON |
Documents disponibles écrits par cet auteur (1)
Faire une suggestion Affiner la recherche
Caregivers' views on cannabis use for their children with autism / Taylor T. SIVORI in Research in Autism Spectrum Disorders, 102 (April 2023)
[article]
Titre : Caregivers' views on cannabis use for their children with autism Type de document : Texte imprimé et/ou numérique Auteurs : Taylor T. SIVORI, Auteur ; Maclain CAPRON, Auteur ; Daniel GRAVES, Auteur ; Jill HARRIS, Auteur ; Roseann C. SCHAAF, Auteur Article en page(s) : p.102130 Langues : Anglais (eng) Mots-clés : Autism ASD Cannabis Caregiver Knowledge Survey Index. décimale : PER Périodiques Résumé : Background Autism is a neurodevelopmental disorder impacting 1 in 44 children that is characterized by decreased social communication and problem behaviors. Despite the increasing accessibility of cannabis, there is limited guidance about its use and usefulness for autism. The purpose of this study is to query caregivers of autistic children about their experience, knowledge and interest in medical cannabis use for their children. Method Survey methodology was used to query caregivers of autistic children between ages five to ten years. Informants recruited through a large children?s hospital in New Jersey and the Autism Speaks website. Descriptive analyses of frequencies and percentages are reported and relationships among socio-demographic variables and survey responses were conducted. Results Of the 4385 surveys sent, 568 responded. Informants were primarily white or Latino, female, and without a college education. Most were not familiar with cannabis use in autism; 7.2 % had experience providing their child with cannabis. Information about cannabis was drawn mainly from the Internet. Eighty-five percent of participants reported that they were willing to try cannabis for their child with ASD to address difficulty focusing, hyperactivity, sensory sensitivities, and anxiety. About half of those respondents were concerned about interactions between cannabis and current medications. Conclusions Findings suggest a willingness among caregivers to use cannabis for their children with ASD, but a need for more informed guidance on this topic. More studies are needed to understand the utility of cannabis for autistic individuals; clear and reputable information about cannabis and ASD is needed. En ligne : https://doi.org/10.1016/j.rasd.2023.102130 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=501
in Research in Autism Spectrum Disorders > 102 (April 2023) . - p.102130[article] Caregivers' views on cannabis use for their children with autism [Texte imprimé et/ou numérique] / Taylor T. SIVORI, Auteur ; Maclain CAPRON, Auteur ; Daniel GRAVES, Auteur ; Jill HARRIS, Auteur ; Roseann C. SCHAAF, Auteur . - p.102130.
Langues : Anglais (eng)
in Research in Autism Spectrum Disorders > 102 (April 2023) . - p.102130
Mots-clés : Autism ASD Cannabis Caregiver Knowledge Survey Index. décimale : PER Périodiques Résumé : Background Autism is a neurodevelopmental disorder impacting 1 in 44 children that is characterized by decreased social communication and problem behaviors. Despite the increasing accessibility of cannabis, there is limited guidance about its use and usefulness for autism. The purpose of this study is to query caregivers of autistic children about their experience, knowledge and interest in medical cannabis use for their children. Method Survey methodology was used to query caregivers of autistic children between ages five to ten years. Informants recruited through a large children?s hospital in New Jersey and the Autism Speaks website. Descriptive analyses of frequencies and percentages are reported and relationships among socio-demographic variables and survey responses were conducted. Results Of the 4385 surveys sent, 568 responded. Informants were primarily white or Latino, female, and without a college education. Most were not familiar with cannabis use in autism; 7.2 % had experience providing their child with cannabis. Information about cannabis was drawn mainly from the Internet. Eighty-five percent of participants reported that they were willing to try cannabis for their child with ASD to address difficulty focusing, hyperactivity, sensory sensitivities, and anxiety. About half of those respondents were concerned about interactions between cannabis and current medications. Conclusions Findings suggest a willingness among caregivers to use cannabis for their children with ASD, but a need for more informed guidance on this topic. More studies are needed to understand the utility of cannabis for autistic individuals; clear and reputable information about cannabis and ASD is needed. En ligne : https://doi.org/10.1016/j.rasd.2023.102130 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=501